Profitelligence Profitelligence · Filing Ledger Open PFE research →

Form 8-K · Current Report · Filed 2025-11-13

Pfizer Completes Acquisition of Metsera, Inc.

On November 13, 2025, Pfizer Inc. completed the acquisition of Metsera, Inc., a Delaware corporation, for an enterprise value of approximately $7.0 billion. Each issued and outstanding share of Metsera common stock was converted into the right to receive $65.60 in cash at closing, with additional contingent value rights tied to specific milestones related to Metsera's clinical trials and FDA approvals.

Filer
Pfizer Inc. PFE · NYSE
Filed
Accession
0000078003-25-000159
CIK
0000078003
Signal
High impactHealthcare

Items reported

Item 8.01

Other Events

Major Legal Settlement Regulatory Approval

Market reaction

Close before filing

$25.87

Next session

-3.1%

Since filing

-3.3%

Latest close

$25.01

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from PFE reporting the same item, with the next session's move:

About Pfizer Inc.

Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.

Exchange NYSE Industry Drug Manufacturers - General Company website ↗

Never miss another PFE filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts